Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Inoue

Showing results (771-780 of 847) with videos related to

Pageof 85
Sort By:
Oncotarget|April 19, 2017
Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladderMakito Miyake, Shunta Hori, Yosuke Morizawa, et al.
European Journal of Immunology|May 16, 2019
B cell-intrinsic MyD88 signaling controls IFN-γ-mediated early IgG2c class switching in mice in response to a particulate adjuvantMichelle Sue Jann Lee, Yayoi Natsume-Kitatani, Burcu Temizoz, et al.
The Journal of Experimental Medicine|December 13, 2022
Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccineesTakeshi Inoue, Ryo Shinnakasu, Chie Kawai, et al.
JMIR Mhealth and Uhealth|May 23, 2022
Adolescent Health Promotion Interventions Using Well-Care Visits and a Smartphone Cognitive Behavioral Therapy App: Randomized Controlled TrialShinichiro Nagamitsu, Ayako Kanie, Kazumi Sakashita, et al.
Journal of Human Genetics|March 9, 2012
Mutations in PRRT2 responsible for paroxysmal kinesigenic dyskinesias also cause benign familial infantile convulsionsShinji Ono, Koh-ichiro Yoshiura, Akira Kinoshita, et al.
Cancer Management and Research|February 25, 2022
Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World DataMakito Miyake, Nobutaka Nishimura, Takuto Shimizu, et al.
Brain & Development|January 13, 2021
Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variantsYu Kobayashi, Jun Tohyama, Yukitoshi Takahashi, et al.
Histopathology|September 1, 2017
Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variantYuichi Yamada, Izumi Kinoshita, Kohashi Kenichi, et al.
Nature Communications|September 20, 2021
Genetic and epigenetic basis of hepatoblastoma diversityGenta Nagae, Shogo Yamamoto, Masashi Fujita, et al.
Virchows Archiv : an International Journal of Pathology|February 16, 2017
Histological and immunohistochemical characteristics of undifferentiated small round cell sarcomas associated with CIC-DUX4 and BCOR-CCNB3 fusion genesYuichi Yamada, Masaaki Kuda, Kenichi Kohashi, et al.
Pageof 85

Showing results (771-780 of 847) with videos related to

Sort By:
Pageof 85
Oncotarget|April 19, 2017
Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladderMakito Miyake, Shunta Hori, Yosuke Morizawa, et al.
European Journal of Immunology|May 16, 2019
B cell-intrinsic MyD88 signaling controls IFN-γ-mediated early IgG2c class switching in mice in response to a particulate adjuvantMichelle Sue Jann Lee, Yayoi Natsume-Kitatani, Burcu Temizoz, et al.
The Journal of Experimental Medicine|December 13, 2022
Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccineesTakeshi Inoue, Ryo Shinnakasu, Chie Kawai, et al.
JMIR Mhealth and Uhealth|May 23, 2022
Adolescent Health Promotion Interventions Using Well-Care Visits and a Smartphone Cognitive Behavioral Therapy App: Randomized Controlled TrialShinichiro Nagamitsu, Ayako Kanie, Kazumi Sakashita, et al.
Journal of Human Genetics|March 9, 2012
Mutations in PRRT2 responsible for paroxysmal kinesigenic dyskinesias also cause benign familial infantile convulsionsShinji Ono, Koh-ichiro Yoshiura, Akira Kinoshita, et al.
Cancer Management and Research|February 25, 2022
Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World DataMakito Miyake, Nobutaka Nishimura, Takuto Shimizu, et al.
Brain & Development|January 13, 2021
Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variantsYu Kobayashi, Jun Tohyama, Yukitoshi Takahashi, et al.
Histopathology|September 1, 2017
Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variantYuichi Yamada, Izumi Kinoshita, Kohashi Kenichi, et al.
Nature Communications|September 20, 2021
Genetic and epigenetic basis of hepatoblastoma diversityGenta Nagae, Shogo Yamamoto, Masashi Fujita, et al.
Virchows Archiv : an International Journal of Pathology|February 16, 2017
Histological and immunohistochemical characteristics of undifferentiated small round cell sarcomas associated with CIC-DUX4 and BCOR-CCNB3 fusion genesYuichi Yamada, Masaaki Kuda, Kenichi Kohashi, et al.
Pageof 85